FI935051A0 - Lanolinderivat som penetrationfraemjande aemnen och anvaendning av dessa i preparat innehaollande laekemedel eller andra biologiskt aktiva substanser - Google Patents

Lanolinderivat som penetrationfraemjande aemnen och anvaendning av dessa i preparat innehaollande laekemedel eller andra biologiskt aktiva substanser

Info

Publication number
FI935051A0
FI935051A0 FI935051A FI935051A FI935051A0 FI 935051 A0 FI935051 A0 FI 935051A0 FI 935051 A FI935051 A FI 935051A FI 935051 A FI935051 A FI 935051A FI 935051 A0 FI935051 A0 FI 935051A0
Authority
FI
Finland
Prior art keywords
substances
preparation
pct
biologically active
penetration
Prior art date
Application number
FI935051A
Other languages
English (en)
Other versions
FI107705B (fi
FI935051A (fi
Inventor
Kleinsorgen Reinhard Von
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI935051A publication Critical patent/FI935051A/fi
Publication of FI935051A0 publication Critical patent/FI935051A0/fi
Application granted granted Critical
Publication of FI107705B publication Critical patent/FI107705B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)
FI935051A 1991-05-15 1993-11-15 Lanoliinijohdannaiset penetraatiota edistävinä aineina ja niiden käyttö lääkeaineita tai muita biologisesti aktiivisia aineita sisältävissä valmisteissa FI107705B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4115849A DE4115849A1 (de) 1991-05-15 1991-05-15 Penetrationsfoerdernde substanz
DE4115849 1991-05-15
PCT/EP1992/000957 WO1992020378A1 (de) 1991-05-15 1992-05-02 Lanolinderivate als penetrationsfördernde substanzen
EP9200957 1992-05-02

Publications (3)

Publication Number Publication Date
FI935051A FI935051A (fi) 1993-11-15
FI935051A0 true FI935051A0 (fi) 1993-11-15
FI107705B FI107705B (fi) 2001-09-28

Family

ID=6431707

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935051A FI107705B (fi) 1991-05-15 1993-11-15 Lanoliinijohdannaiset penetraatiota edistävinä aineina ja niiden käyttö lääkeaineita tai muita biologisesti aktiivisia aineita sisältävissä valmisteissa

Country Status (24)

Country Link
US (1) US5492698A (fi)
EP (1) EP0584126B1 (fi)
JP (1) JP2547301B2 (fi)
KR (1) KR100248365B1 (fi)
AT (1) ATE151643T1 (fi)
AU (1) AU658626B2 (fi)
CA (1) CA2103060C (fi)
CZ (1) CZ284034B6 (fi)
DE (2) DE4115849A1 (fi)
DK (1) DK0584126T3 (fi)
ES (1) ES2103369T3 (fi)
FI (1) FI107705B (fi)
GR (1) GR3024015T3 (fi)
HU (1) HU219225B (fi)
IE (1) IE80626B1 (fi)
IL (1) IL101710A (fi)
MY (1) MY131090A (fi)
NO (1) NO306762B1 (fi)
NZ (1) NZ242722A (fi)
PH (1) PH31463A (fi)
SK (1) SK126093A3 (fi)
WO (1) WO1992020378A1 (fi)
YU (1) YU47192A (fi)
ZA (1) ZA923486B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07300419A (ja) * 1993-12-06 1995-11-14 Lansinoh Lab Inc ラノリン／ラノリン酸エステル皮膚処置用組成物
AU4990797A (en) * 1996-10-24 1998-05-15 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US20060002959A1 (en) * 1996-11-14 2006-01-05 Government Of The United States Skin-sctive adjuvants for transcutaneous immuization
US6797276B1 (en) * 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US20040258703A1 (en) * 1997-11-14 2004-12-23 The Government Of The Us, As Represented By The Secretary Of The Army Skin-active adjuvants for transcutaneous immunization
DE19834007C1 (de) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung
JP4932086B2 (ja) * 1999-04-08 2012-05-16 インターセル ユーエスエイ、インコーポレイテッド 経皮的免疫のための乾燥製剤
ES2310201T3 (es) * 2001-02-13 2009-01-01 Government Of The United States Of America, As Represented By The Secretary Of The Army Vacuna para inmunizacion transcutanea contra la diarrea de los viajeros.
EP1392272B1 (en) * 2001-05-11 2014-08-06 Merrion Research III Limited Permeation enhancers
EA007956B1 (ru) * 2003-11-05 2007-02-27 Алишир Вейс Оглу Мусаев Способ приготовления препарата на основе нафталановой нефти
US20060124246A1 (en) * 2004-12-14 2006-06-15 Pitney Bowes Incorporated Moistening fluids that destroy and/or inhibit the growth of biological organisms
GB2425475A (en) * 2005-01-29 2006-11-01 Croda Int Plc PEG or PPG lanolin derivatives as antipruritic agents

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527864A (en) * 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
LU62873A1 (fi) * 1971-03-29 1972-12-07
FR2155777A1 (en) * 1971-10-04 1973-05-25 Innothera Lab Sa Mixt of lanolin deriv, lauryl alcohol derivs and polyethylene - glycol - for use as a cosmetic cleansing agent and pharmaceutical exc
US3891757A (en) * 1971-11-11 1975-06-24 Alza Corp Anaesthetic topical and percutaneous administration with selected promoters
US3903256A (en) * 1972-02-07 1975-09-02 Procter & Gamble Compositions for topical application of animal tissue and method of enhancing penetration thereof
US3896238A (en) * 1972-04-05 1975-07-22 Procter & Gamble Dermatological compositions
US3952099A (en) * 1973-03-13 1976-04-20 The Procter & Gamble Company Dermatological compositions
US4046886A (en) * 1975-01-17 1977-09-06 The Procter & Gamble Company Dermatological compositions
US4405616A (en) * 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4130667A (en) * 1976-01-12 1978-12-19 The Procter & Gamble Company Dermatological compositions
US4146649A (en) * 1976-10-14 1979-03-27 Faberge, Incorporated Skin moisturizing composition containing a polyethoxy fatty alcohol and a polyethoxy glycoside
US4335115A (en) * 1976-11-01 1982-06-15 The Procter & Gamble Company Anti-acne composition
AU520987B2 (en) * 1978-05-08 1982-03-11 Victor Alexander Garten Anti-arthritic preparation
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4343798A (en) * 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
SU1090400A1 (ru) * 1982-05-05 1984-05-07 Предприятие П/Я Г-4740 Крем дл кожи лица
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
EP0147883A3 (en) * 1983-12-21 1986-12-30 Janssen Pharmaceutica N.V. Aqueous non-aggressive anthelmintic pour-on formulations
JPS6124517A (ja) * 1984-07-11 1986-02-03 Nichiban Co Ltd 循環器疾患用貼布治療製剤
EP0189861A3 (en) * 1985-01-26 1988-02-17 Showa Denko Kabushiki Kaisha Percutaneous absorption accelerator for ionic water-soluble medicine
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
EP0266968A3 (en) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent
SU1532046A1 (ru) * 1987-08-05 1989-12-30 Научно-производственное объединение "Аэрозоль" Крем дл рук
US5057497A (en) * 1987-11-10 1991-10-15 Calam & Associates, Inc. Oral method for the maintenance of healthy gingival tissues using TRF
DE3807283A1 (de) * 1988-03-05 1989-09-14 Basf Ag Verfahren zur herstellung eines pflasters zur transdermalen anwendung pharmazeutischer wirkstoffe
ZA898331B (en) * 1988-11-22 1990-07-25 Hoffmann La Roche Pharmaceutical compositions

Also Published As

Publication number Publication date
FI107705B (fi) 2001-09-28
IL101710A (en) 1998-03-10
YU47192A (sh) 1997-08-22
IL101710A0 (en) 1992-12-30
NO306762B1 (no) 1999-12-20
EP0584126A1 (de) 1994-03-02
PH31463A (en) 1998-11-03
NZ242722A (en) 1994-10-26
CA2103060C (en) 1999-11-30
ES2103369T3 (es) 1997-09-16
HU219225B (en) 2001-03-28
IE80626B1 (en) 1998-10-21
DK0584126T3 (da) 1997-10-20
AU658626B2 (en) 1995-04-27
WO1992020378A1 (de) 1992-11-26
HUT67321A (en) 1995-03-28
FI935051A (fi) 1993-11-15
DE4115849A1 (de) 1992-11-19
NO934107L (no) 1993-11-12
HU9303230D0 (en) 1994-03-28
GR3024015T3 (en) 1997-10-31
EP0584126B1 (de) 1997-04-16
JPH06503581A (ja) 1994-04-21
CZ238093A3 (en) 1994-03-16
ZA923486B (en) 1993-01-27
DE59208362D1 (de) 1997-05-22
KR100248365B1 (ko) 2000-04-01
AU1670992A (en) 1992-12-30
US5492698A (en) 1996-02-20
CZ284034B6 (cs) 1998-07-15
NO934107D0 (no) 1993-11-12
CA2103060A1 (en) 1992-11-16
MY131090A (en) 2007-07-31
SK126093A3 (en) 1994-09-07
JP2547301B2 (ja) 1996-10-23
ATE151643T1 (de) 1997-05-15
IE921538A1 (en) 1992-11-18

Similar Documents

Publication Publication Date Title
FI935051A0 (fi) Lanolinderivat som penetrationfraemjande aemnen och anvaendning av dessa i preparat innehaollande laekemedel eller andra biologiskt aktiva substanser
AR004483A1 (es) Compuestos para uso en terapia que comprenden un residuo de 1,3-propano diol como agente enlazante entre el residuo de ácido graso y un residuo bioactivo, usos de dichos compuestos y medicamentos , alimentos y formulaciones para el cuidado o tratamiento de la piel que comprenden a dichos compuestos
KR880000089A (ko) 서방형 약제 조성물
ES2075011T3 (es) Uso de sales del acido gamma-hidroxibutirico para preparar composiciones farmaceuticas para uso en el tratamiento del alcoholismo, y las composiciones obtenidas.
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
NO971951L (no) Farmasöytiske preparater
ATE226815T1 (de) Herstellung von arzneimitteln
DE69414840T2 (de) Akzeptabele pharmazeutische zusammensetzung enthaltend einen alkohol und einen hydrophalischen wirkstoff
DE69927963D1 (de) Gelierbare pharmazeutische zusammensetzungen
PT801649E (pt) Derivados de hidroxilamina uteis para aumentar a producao de proteinas moleculares adventicias e sua preparacao
DE3382087D1 (de) Praeparate zur behandlung von wunden der hautoberflaeche und verfahren zur herstellung derartiger praeparate.
DE3775960D1 (de) Pharmazeutische zubereitung sowie verfahren zur herstellung derselben.
BR9507846A (pt) Composição farmacéutica estável e fortemente concentrada de principio ativo da classe dos taxóides escolhido entre o docetaxol ou os derivados do docetaxol processo de preparação desta composição e utilização de uma solução congelada ou liofilizada
DK1150713T3 (da) Vaccineformulering der omfatter monoglycerider eller fedtsyrer som adjuvans
NO20013117L (no) Kosmetisk preparat av spraytype og matriks anvendt i preparatet for dermal tilforsel
NO179632C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat som inneholder podofyllotoksin
JPS55154904A (en) Repellent composition
JPS6425719A (en) Anti-inflammatory and analgesic cream agent
ATE310527T1 (de) Lipide zur stimulierung der immunreaktion
DE59002790D1 (de) Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO).
EP0270282A3 (en) Oleic acid esters and pharmaceutical compositions
TH8733A (th) ตัวปลุกฤทธิ์โปรตีนไคเนสเป็นตัวกระตุ้นการผลิตเมลานิน
ATE140623T1 (de) Pharmazeutische zusammensetzungen für die orale, kutane und intravaginale anwendung in form eines schaums